TG Therapeutics,
Country
USA
Краткое название
TG Therapeutics,
Headquarters
787 Seventh Avenue 48th Floor
Members of the board
Michael S. Weiss,
Executive Chairman,
Interim President and Chief Executive Officer
Sean A. Power,
Chief Financial Officer
Robert Niecestro, PhD.,
Executive Vice President, Clinical & Regulatory
Categories medicine
Oncology
Stage of the project
Production
Disease
Blood cancer, Thyroid and vascular gland cancer, Virilia cancer, Muliebria cancer, Breast cancer, Lung cancer, Intestine cancer, Gastric cancer
Ticker
TGTX
Current owners
Michael S. Weiss,
Neil Herskowitz,
Laurence N. Charney,
William J. Kennedy, PhD.,
Mark Schoenebaum, M.D.,
Yann Echelard, Ph.D.
Technology
Cell Technologies, Homogeneous antibodies, Devices, Technologies, Pharmaceuticals, Chemistry